Boston Scientific Corp. Company Profile (NYSE:BSX)

About Boston Scientific Corp.

Boston Scientific Corp. logoBoston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP), Endoscopy, Urology and Pelvic Health, and Neuromodulation. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and PI businesses. Its Rhythm Management segment consists of CRM and EP businesses. Its MedSurg segment consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its interventional cardiology products include Drug-Eluting Coronary Stent Systems, Core Coronary Technology, Intravascular Imaging and Structural Heart Therapy. Its peripheral products include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: BSX
  • CUSIP: 10113710
Key Metrics:
  • Previous Close: $23.72
  • 50 Day Moving Average: $23.874
  • 200 Day Moving Average: $22.298
  • 52-Week Range: $15.67 - $24.79
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 18.85
  • P/E Growth: -1.430
  • Market Cap: $32.24B
  • Outstanding Shares: 1,360,743,000
  • Beta: 0.99
  • Net Margins: -4.34%
  • Return on Equity: 22.66%
  • Return on Assets: 8.01%
  • Debt-to-Equity Ratio: 0.83%
  • Current Ratio: 1.05%
  • Quick Ratio: 0.74%
Additional Links:
Companies Related to Boston Scientific Corp.:

Analyst Ratings

Consensus Ratings for Boston Scientific Corp. (NYSE:BSX) (?)
Ratings Breakdown: 4 Hold Ratings, 20 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $25.23 (6.22% upside)

Analysts' Ratings History for Boston Scientific Corp. (NYSE:BSX)
DateFirmActionRatingPrice TargetDetails
9/1/2016ArgusUpgradeHold -> Buy$23.82 -> $33.00View Rating Details
8/3/2016Citigroup Inc.Boost Price TargetBuy$26.00 -> $28.00View Rating Details
7/31/2016Evercore ISIReiterated RatingBuy$25.50 -> $26.00View Rating Details
7/29/2016RBC Capital MarketsReiterated RatingBuy$28.00View Rating Details
7/29/2016JPMorgan Chase & Co.Boost Price TargetOverweight$24.00 -> $27.00View Rating Details
7/29/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details
7/29/2016Leerink SwannReiterated RatingBuyView Rating Details
7/29/2016Jefferies GroupBoost Price TargetHold$21.00 -> $24.00View Rating Details
7/29/2016WedbushBoost Price TargetNeutral$23.00 -> $25.00View Rating Details
7/29/2016Needham & Company LLCBoost Price TargetBuy$26.00 -> $28.00View Rating Details
7/28/2016Benchmark Co.Boost Price TargetBuy$25.00 -> $31.00View Rating Details
6/21/2016Piper Jaffray Cos.Reiterated RatingOverweight$26.00View Rating Details
6/8/2016GuggenheimInitiated CoverageBuy$26.00View Rating Details
5/23/2016BTIG ResearchDowngradeBuy -> Neutral$24.20View Rating Details
5/12/2016Royal Bank Of CanadaReiterated RatingOutperform$25.00View Rating Details
4/28/2016Barclays PLCBoost Price TargetOverweight$23.00 -> $25.00View Rating Details
4/28/2016Stifel NicolausBoost Price TargetBuy$22.00 -> $25.00View Rating Details
4/8/2016Goldman Sachs Group Inc.Boost Price Target$21.00 -> $22.00View Rating Details
3/27/2016Morgan StanleyReiterated RatingOverweight$22.00View Rating Details
3/25/2016Bank of America Corp.Reiterated RatingBuy$23.00View Rating Details
3/18/2016Longbow ResearchInitiated CoverageBuyView Rating Details
3/17/2016NomuraInitiated CoverageBuy$22.00View Rating Details
3/12/2016Deutsche Bank AGReiterated RatingHoldView Rating Details
2/25/2016SunTrust Banks Inc.Initiated CoverageBuy$21.00View Rating Details
1/4/2016Sterne Agee CRTBoost Price TargetBuy$21.00 -> $22.50View Rating Details
7/7/2015StephensInitiated CoverageOverweight$21.00View Rating Details
3/20/2015Raymond James Financial Inc.Initiated CoverageOutperform$21.00View Rating Details
3/16/2015BMO Capital MarketsBoost Price TargetOutperform$18.00 -> $19.00View Rating Details
3/3/2015Oppenheimer Holdings Inc.Boost Price TargetMarket Perform$16.00 -> $17.00View Rating Details
2/5/2015JMP SecuritiesBoost Price TargetMarket Outperform$15.00 -> $17.00View Rating Details
2/5/2015CRT CapitalBoost Price TargetBuy$16.00 -> $18.00View Rating Details
(Data available from 9/29/2014 forward)


Earnings History for Boston Scientific Corp. (NYSE:BSX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216$0.27$0.27$2.05 billion$2.13 billionViewListenView Earnings Details
4/27/2016Q116$0.24$0.28$1.91 billion$1.96 billionViewListenView Earnings Details
2/4/2016Q415$0.25$0.26$2.00 billion$1.98 billionViewListenView Earnings Details
10/28/2015Q315$0.23$0.24$1.86 billion$1.89 billionViewListenView Earnings Details
7/23/2015Q215$0.21$0.22$1.83 billion$1.84 billionViewListenView Earnings Details
4/28/2015Q115$0.21$0.21$1.78 billion$1.77 billionViewListenView Earnings Details
2/4/2015Q414$0.21$0.22$1.91 billion$1.89 billionViewListenView Earnings Details
10/22/2014Q314$0.20$0.20$1.82 billion$1.85 billionViewListenView Earnings Details
7/24/2014Q214$0.19$0.18$1.87 billion$1.87 billionViewListenView Earnings Details
4/29/2014Q114$0.18$0.16$1.80 billion$1.77 billionViewListenView Earnings Details
2/4/2014Q4$0.13$0.21$1.83 billion$1.84 billionViewListenView Earnings Details
10/24/2013Q313$0.09$0.17$1.73 billion$1.74 billionViewListenView Earnings Details
7/25/2013Q2 2013$0.10$0.18$1.78 billion$1.81 billionViewListenView Earnings Details
4/25/2013Q1 2013$0.09$0.16$1.79 billion$1.76 billionViewListenView Earnings Details
1/29/2013Q4 2012$0.11$0.18$1.76 billion$1.82 billionViewListenView Earnings Details
10/18/2012$0.11($0.52)ViewN/AView Earnings Details
7/26/2012$0.08$0.17ViewN/AView Earnings Details
4/19/2012$0.13$0.15ViewN/AView Earnings Details
2/2/2012$0.08$0.07ViewN/AView Earnings Details
10/20/2011$0.09$0.15ViewN/AView Earnings Details
7/28/2011$0.08$0.17ViewN/AView Earnings Details
4/20/2011$0.04$0.01ViewN/AView Earnings Details
2/1/2011$0.09$0.15ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Boston Scientific Corp. (NYSE:BSX)
Current Year EPS Consensus Estimate: $1.1 EPS
Next Year EPS Consensus Estimate: $1.26 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.24$0.24$0.24
Q2 20165$0.26$0.27$0.26
Q3 20164$0.26$0.27$0.27
Q4 20165$0.28$0.29$0.29
Q1 20172$0.30$0.30$0.30
Q2 20172$0.30$0.32$0.31
Q3 20172$0.31$0.32$0.32
Q4 20172$0.33$0.34$0.34
(Data provided by Zacks Investment Research)


Dividend History for Boston Scientific Corp. (NYSE:BSX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Boston Scientific Corp. (NYSE:BSX)
Insider Ownership Percentage: 1.31%
Institutional Ownership Percentage: 92.06%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2016John Bradley SorensonSVPSell2,500$23.90$59,750.00View SEC Filing  
8/1/2016Michael F MahoneyCEOSell44,400$24.44$1,085,136.00View SEC Filing  
8/1/2016Timothy A PrattEVPSell24,000$24.46$587,040.00View SEC Filing  
7/20/2016David A PierceSVPSell2,480$24.03$59,594.40View SEC Filing  
7/20/2016Michael P. PhalenEVPSell35,000$24.03$841,050.00View SEC Filing  
6/1/2016Michael F MahoneyCEOSell100,000$22.69$2,269,000.00View SEC Filing  
6/1/2016Timothy A PrattEVPSell24,229$22.66$549,029.14View SEC Filing  
5/11/2016John Bradley SorensonSVPSell2,800$22.15$62,020.00View SEC Filing  
5/10/2016Keith D DawkinsEVPSell80,000$22.15$1,772,000.00View SEC Filing  
5/6/2016Jeffrey B MirvissSVPSell24,659$21.94$541,018.46View SEC Filing  
5/3/2016Joseph Michael FitzgeraldEVPSell79,960$21.81$1,743,927.60View SEC Filing  
5/2/2016Michael F MahoneyCEOSell100,000$22.12$2,212,000.00View SEC Filing  
5/2/2016Timothy A PrattEVPSell24,000$21.93$526,320.00View SEC Filing  
4/27/2016Kevin J BallingerSVPSell111,807$21.62$2,417,267.34View SEC Filing  
4/27/2016Timothy A PrattEVPSell39,927$21.40$854,437.80View SEC Filing  
4/4/2016Jeffrey B MirvissSVPSell18,422$19.00$350,018.00View SEC Filing  
4/1/2016Michael F MahoneyCEOSell100,000$18.90$1,890,000.00View SEC Filing  
4/1/2016Timothy A PrattEVPSell24,000$18.73$449,520.00View SEC Filing  
3/11/2016Kevin J BallingerSVPSell16,705$18.00$300,690.00View SEC Filing  
3/8/2016Karen PrangeSVPSell14,747$17.27$254,680.69View SEC Filing  
3/2/2016Michael P. PhalenEVPSell10,665$17.17$183,118.05View SEC Filing  
3/1/2016Michael F MahoneyCEOSell100,000$16.96$1,696,000.00View SEC Filing  
3/1/2016Timothy A PrattEVPSell15,068$16.97$255,703.96View SEC Filing  
2/29/2016Kevin J. BallingerSVPSell2,114$17.17$36,297.38View SEC Filing  
2/29/2016Michael P. PhalenEVPSell1,819$17.19$31,268.61View SEC Filing  
2/25/2016Daniel J BrennanCFOSell103,211$17.22$1,777,293.42View SEC Filing  
2/25/2016Kevin J. BallingerSVPSell1,903$17.48$33,264.44View SEC Filing  
2/25/2016Michael P. PhalenEVPSell34,106$17.28$589,351.68View SEC Filing  
2/17/2016Kevin J. BallingerSVPSell7,616$17.37$132,289.92View SEC Filing  
2/12/2016Charles J DockendorffDirectorBuy30,000$16.49$494,700.00View SEC Filing  
2/8/2016Karen PrangeSVPSell6,216$16.05$99,766.80View SEC Filing  
1/8/2016Timothy A PrattEVPSell7,160$17.67$126,517.20View SEC Filing  
1/7/2016Kevin J BallingerSVPSell19,059$17.73$337,916.07View SEC Filing  
1/5/2016Jeffrey B MirvissSVPSell9,953$18.00$179,154.00View SEC Filing  
12/1/2015Timothy A. PrattEVPSell24,000$18.43$442,320.00View SEC Filing  
11/16/2015Ernest MarioDirectorSell125,000$17.63$2,203,750.00View SEC Filing  
11/9/2015John Bradley SorensonSVPSell4,469$18.68$83,480.92View SEC Filing  
11/9/2015Joseph Michael FitzgeraldEVPSell26,220$18.58$487,167.60View SEC Filing  
11/5/2015Timothy A PrattEVPSell19,598$19.00$372,362.00View SEC Filing  
10/28/2015Jeffrey B MirvissSVPSell9,492$18.00$170,856.00View SEC Filing  
10/28/2015Timothy A PrattEVPSell3,500$18.00$63,000.00View SEC Filing  
10/5/2015Timothy A PrattEVPSell3,500$17.34$60,690.00View SEC Filing  
10/1/2015Timothy A. PrattEVPSell17,000$16.33$277,610.00View SEC Filing  
8/21/2015John E AbeleDirectorBuy200,000$16.77$3,354,000.00View SEC Filing  
8/19/2015John E AbeleDirectorBuy200,000$17.48$3,496,000.00View SEC Filing  
8/17/2015John E AbeleDirectorBuy100,000$17.50$1,750,000.00View SEC Filing  
7/7/2015Karen PrangeSVPSell17,456$17.66$308,272.96View SEC Filing  
5/29/2015Maulik NanavatySVPSell71,558$18.52$1,325,254.16View SEC Filing  
5/28/2015Wendy CarruthersSVPSell42,281$17.91$757,252.71View SEC Filing  
5/18/2015Ernest MarioDirectorSell50,000$18.09$904,500.00View SEC Filing  
5/14/2015John E SununuDirectorSell10,000$17.87$178,700.00View SEC Filing  
5/11/2015John Bradley SorensonSVPSell8,735$17.49$152,775.15View SEC Filing  
3/20/2015David A PierceSVPSell18,050$18.00$324,900.00View SEC Filing  
3/20/2015Michael P PhalenEVPSell46,085$17.94$826,764.90View SEC Filing  
3/16/2015Michael P PhalenEVPSell30,022$17.18$515,777.96View SEC Filing  
3/13/2015John Bradley SorensonSVPSell3,830$16.84$64,497.20View SEC Filing  
3/9/2015David A PierceSVPSell2,561$16.54$42,358.94View SEC Filing  
3/3/2015David A PierceSVPSell8,983$16.79$150,824.57View SEC Filing  
3/3/2015Michael P PhalenEVPSell12,768$16.79$214,374.72View SEC Filing  
2/27/2015David A PierceSVPSell19,046$16.80$319,972.80View SEC Filing  
2/27/2015Michael P PhalenEVPSell1,819$16.80$30,559.20View SEC Filing  
2/19/2015David A PierceSVPSell11,958$16.46$196,828.68View SEC Filing  
2/19/2015Michael P PhalenEVPSell13,188$16.44$216,810.72View SEC Filing  
2/10/2015Joseph Michael FitzgeraldEVPSell61,208$14.66$897,309.28View SEC Filing  
2/9/2015David A PierceSVPSell5,000$14.66$73,300.00View SEC Filing  
2/6/2015Kevin J BallingerSVPSell21,408$15.06$322,404.48View SEC Filing  
1/20/2015Michael P PhalenEVPSell10,000$14.54$145,400.00View SEC Filing  
1/8/2015David A PierceSVPSell18,612$14.31$266,337.72View SEC Filing  
1/8/2015Michael P PhalenEVPSell27,589$14.31$394,798.59View SEC Filing  
1/5/2015Michael P PhalenEVPSell10,000$13.75$137,500.00View SEC Filing  
12/10/2014Karen PrangeSVPSell19,753$12.64$249,677.92View SEC Filing  
12/8/2014David A PierceSVPSell5,000$12.90$64,500.00View SEC Filing  
12/1/2014Ernest MarioDirectorSell10,000$12.96$129,600.00View SEC Filing  
11/28/2014Michael F MahoneyCEOBuy11,700$12.89$150,813.00View SEC Filing  
11/10/2014Edward J LudwigDirectorBuy10,000$13.38$133,800.00View SEC Filing  
11/5/2014John E SununuDirectorSell8,997$13.38$120,379.86View SEC Filing  
11/3/2014Ernest MarioDirectorSell10,000$13.30$133,000.00View SEC Filing  
10/8/2014Ernest MarioDirectorSell10,000$12.06$120,600.00View SEC Filing  
9/2/2014Ernest MarioDirectorSell10,000$12.60$126,000.00View SEC Filing  
8/15/2014Michael P PhalenEVPSell11,471$12.58$144,305.18View SEC Filing  
8/1/2014Ernest MarioDirectorSell10,000$12.58$125,800.00View SEC Filing  
7/30/2014David A PierceSVPSell157$12.97$2,036.29View SEC Filing  
7/15/2014Michael P PhalenEVPSell67,500$13.04$880,200.00View SEC Filing  
7/1/2014Ernest MarioDirectorSell10,000$12.95$129,500.00View SEC Filing  
6/16/2014Michael P PhalenEVPSell13,500$13.02$175,770.00View SEC Filing  
6/2/2014Ernest MarioDirectorSell10,000$12.88$128,800.00View SEC Filing  
5/15/2014Michael PhalenEVPSell13,500$12.76$172,260.00View SEC Filing  
5/1/2014Ernest MarioDirectorSell10,000$12.58$125,800.00View SEC Filing  
4/15/2014Michael PhalenEVPSell13,500$13.25$178,875.00View SEC Filing  
4/1/2014Ernest MarioDirectorSell10,000$13.55$135,500.00View SEC Filing  
3/17/2014Michael PhalenEVPSell13,500$13.05$176,175.00View SEC Filing  
3/6/2014David PierceSVPSell5,316$13.44$71,447.04View SEC Filing  
3/6/2014Michael PhalenEVPSell7,281$13.44$97,856.64View SEC Filing  
2/27/2014David PierceSVPSell2,057$13.29$27,337.53View SEC Filing  
2/27/2014Michael PhalenEVPSell3,166$13.29$42,076.14View SEC Filing  
2/21/2014David PierceSVPSell3,199$13.22$42,290.78View SEC Filing  
2/21/2014Michael PhalenEVPSell3,222$13.22$42,594.84View SEC Filing  
2/18/2014Michael PhalenEVPSell13,500$13.30$179,550.00View SEC Filing  
2/13/2014Kristina JohnsonDirectorSell18,000$13.01$234,180.00View SEC Filing  
2/6/2014Ernest MarioDirectorSell17,104$12.80$218,931.20View SEC Filing  
2/3/2014Ernest MarioDirectorSell10,000$13.19$131,900.00View SEC Filing  
1/6/2014Ernest MarioDirectorSell10,000$12.50$125,000.00View SEC Filing  
12/26/2013Ernest MarioDirectorSell10,000$12.06$120,600.00View SEC Filing  
11/26/2013Jeffrey CapelloCFOSell85,106$11.82$1,005,952.92View SEC Filing  
11/11/2013Jeffrey MirvissSVPSell26,000$11.91$309,660.00View SEC Filing  
8/29/2013Jeffrey CapelloCFOSell525,000$10.68$5,607,000.00View SEC Filing  
8/16/2013Joseph Michael FitzgeraldSVPSell9,202$11.02$101,406.04View SEC Filing  
8/14/2013Kevin BallingerSVPSell38,171$11.28$430,568.88View SEC Filing  
5/31/2013Jeffrey B MirvissSVPSell10,941$9.37$102,517.17View SEC Filing  
5/30/2013Wendy CarruthersSVPSell25,001$9.16$229,009.16View SEC Filing  
5/29/2013Nelda J ConnorsDirectorSell24,116$9.17$221,143.72View SEC Filing  
5/6/2013Ernest MarioDirectorBuy30,000$7.76$232,800.00View SEC Filing  
11/13/2012Nj Nicholas JrDirectorBuy20,000$5.28$105,600.00View SEC Filing  
11/9/2012Nj Nicholas JrDirectorBuy25,000$5.17$129,250.00View SEC Filing  
8/6/2012Ernest MarioDirectorBuy32,000$5.29$169,280.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Boston Scientific Corp. (NYSE:BSX)
DateHeadline logoCan Boston Scientific Corporation (NYSE:BSX) Outdo Yearly EPS Estimate Of $1.17? - Stocks Daily (NYSE:BSX) - September 28 at 3:45 PM
News IconGeneral Electric Company (NYSE:GE) & Boston Scientific Corporation (NYSE:BSX) Stocks to Keep Your Eyes on - Money News (NYSE:BSX) - September 28 at 3:45 PM logoHow Has Boston Scientific’s Stock Performed Recently? (NYSE:BSX) - September 28 at 3:45 PM logoBoston Scientific’s Acquisition of EndoChoice: Must-Know Details (NYSE:BSX) - September 28 at 3:45 PM logoBoston Scientific to Buy Endoscopy Company in $210M Deal (NYSE:BSX) - September 28 at 8:45 AM
News IconTop Gainers of the Day: Boston Scientific Corporation (NYSE:BSX) from Medical Appliances & Equipment (NYSE:BSX) - September 28 at 8:45 AM
News IconAnalyst Ratings On Watch List HP Inc (HPQ), Boston Scientific Corporation (BSX) (NYSE:BSX) - September 28 at 8:45 AM logoBoston Scientific to Acquire EndoChoice for $210 Million (NYSE:BSX) - September 28 at 8:45 AM
News IconQuarterly EPS Forecast Review: Boston Scientific Corporation (NYSE:BSX) (NYSE:BSX) - September 28 at 8:45 AM
News IconVigorous Stocks Need to Consider- Boston Scientific Corporation (NYSE:BSX), Medivation, Inc. (NASDAQ:MDVN) - Street Wise Report (press release) (blog) (NYSE:BSX) - September 27 at 3:55 PM logo15 Biggest Mid-Day Gainers For Tuesday - Benzinga (NYSE:BSX) - September 27 at 3:55 PM logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of EndoChoice Holdings, Inc. to Boston Scientific Corporation for $8.00 Per Share is Fair to Shareholders -- GI (NYSE:BSX) - September 27 at 3:55 PM logoA Peek Into The Markets: U.S. Stock Futures Gain Ahead Of Economic Data - Benzinga (NYSE:BSX) - September 27 at 8:33 AM logoBoston Scientific to Acquire EndoChoice for $210 Million - Wall Street Journal (NYSE:BSX) - September 27 at 8:33 AM logoBoston Scientific to Acquire EndoChoice (NYSE:BSX) - September 27 at 8:33 AM logoBOSTON SCIENTIFIC CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NYSE:BSX) - September 27 at 8:33 AM logo[$$] Boston Scientific to Buy EndoChoice (NYSE:BSX) - September 27 at 8:33 AM logoEarly movers: TWTR, VLKAY, AXP, SJM, AZO & more (NYSE:BSX) - September 27 at 8:33 AM logoBRIEF-Boston Scientific to acquire EndoChoice for $8.00/share (NYSE:BSX) - September 27 at 7:01 AM logoBoston Scientific acquires platform GI firm EndoChoice for $8 a share (NYSE:BSX) - September 27 at 7:01 AM
News IconActive Biotech Stock News: Skyline Medical Inc. (SKLN), Boston Scientific Corporation (BSX) - The Independent Republic (NYSE:BSX) - September 26 at 4:09 PM
News IconWorth Watching Stocks on the Move: Boston Scientific Corporation (NYSE:BSX), Nokia Corp (ADR)(NYSE:NOK) - NYSE Journal (press release) (NYSE:BSX) - September 26 at 4:09 PM
News IconGlobal Remote Patient Monitoring Systems Market Research Report 2016: GE Healthcare Ltd. (UK), Boston Scientific Corporation (US) (NYSE:BSX) - September 26 at 8:44 AM
News IconHC Stocks Analysis! Boston Scientific Corporation (BSX), Sarepta Therapeutics Inc (NASDAQ:SRPT) - share market updates (press release) (NYSE:BSX) - September 23 at 3:25 PM
News IconHC Stocks to watch for! Bristol-Myers Squibb Co (BMY), Boston Scientific Corporation (NYSE:BSX) - share market updates (press release) (NYSE:BSX) - September 23 at 3:25 PM
News IconBoston Scientific Corporation (NYSE:BSX) from Medical Appliances & Equipment – Todays Top Gains (NYSE:BSX) - September 22 at 4:07 PM logoDiamond Hill Buys Ford, Sells Boston Scientific (NYSE:BSX) - September 22 at 8:15 AM logoUptrend Call Working As Boston Scientific Stock Rises 29.5% (BSX) (NYSE:BSX) - September 21 at 3:25 PM
News IconLeading stocks in today’s market: Boston Scientific Corporation (NYSE:BSX) (NYSE:BSX) - September 21 at 3:25 PM
News IconSizzling Stock- Boston Scientific Corporation's (BSX) - Hot Stocks Point (NYSE:BSX) - September 21 at 8:31 AM
News IconResearch Report for: Boston Scientific Corporation (NYSE:BSX) (NYSE:BSX) - September 20 at 9:52 AM
News IconBoston Scientific Receives CE Mark For LOTUS Edge Valve System (NYSE:BSX) - September 19 at 4:50 PM
News IconBoston Scientific Receives CE Mark For LOTUS Edge Valve System (NYSE:BSX) - September 19 at 4:50 PM logoStock is down at $23.50 Boston Scientific Receives CE Mark For… (NYSE:BSX) - September 19 at 4:50 PM logoStock is down at $23.50 Boston Scientific Receives CE Mark For… (NYSE:BSX) - September 19 at 4:50 PM
News IconShares of American Capital Agency Corp. (NASDAQ:AGNC) & Boston Scientific Corporation (NYSE:BSX) Stocks News ... - Money News (NYSE:BSX) - September 19 at 8:46 AM logoBoston Scientific's (BSX) LOTUS Edge Valve System Receives CE ... - (NYSE:BSX) - September 19 at 8:46 AM logoBoston Scientific Receives CE Mark For LOTUS Edge™ Valve System (NYSE:BSX) - September 19 at 8:46 AM logo2:56 am Boston Scientific's LOTUS Edge Valve System receives CE Mark (NYSE:BSX) - September 19 at 8:46 AM
News IconHC Stocks in Front Line! Aerie Pharmaceuticals Inc (AERI), Boston Scientific Corporation (NYSE:BSX) - share market updates (press release) (NYSE:BSX) - September 16 at 3:55 PM
News IconA look at a High Market Cap Stock: Boston Scientific Corporation, BSX - The Daily Leicester (NYSE:BSX) - September 16 at 3:55 PM logoBoston Scientific emerges as likely buyer for Veniti (NYSE:BSX) - September 16 at 11:55 AM
News IconNews Buzz in Analytic Views- Allergan plc (NYSE:AGN), Boston Scientific Corporation (NYSE:BSX) - Seneca Globe (NYSE:BSX) - September 15 at 3:51 PM logoStocks Buzz: Micron Technology, Inc. (MU) Boston Scientific Corporation (BSX) United States Steel Corp. (X) - iStreetWire (NYSE:BSX) - September 15 at 3:51 PM
News IconHC Stocks News Ring= Boston Scientific (BSX), Sarepta Therapeutics Inc (NASDAQ:SRPT) - share market updates (press release) (NYSE:BSX) - September 15 at 3:51 PM
News IconBoston Scientific Corporation (BSX) - Medical Equipment - Deals and Alliances Profile (NYSE:BSX) - September 15 at 12:53 PM
News IconAnalyst Predictions Are In For Boston Scientific Corporation (NYSE:BSX), Starbucks Corporation (NASDAQ:SBUX) - Yankee Analysts (NYSE:BSX) - September 14 at 9:12 PM logoCramer: This Is a Market of Stocks, not a Market of Markets (NYSE:BSX) - September 14 at 9:12 PM logoBoston Scientific calls buy time for rally (NYSE:BSX) - September 14 at 8:07 AM logoBoston Scientific Corp. – Value Analysis (NYSE:BSX) : September 13, 2016 (NYSE:BSX) - September 14 at 8:07 AM


Boston Scientific Corp. (NYSE:BSX) Chart for Thursday, September, 29, 2016

Last Updated on 9/29/2016 by Staff